Eutilex.Co.,Ltd (KOSDAQ:263050)

South Korea · Delayed Price · Currency is KRW

959.00

+221.00 (29.95%)

At close: Feb 6, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharmaceuticals	9.53B	131.65M	215.66M	73.54M	2.04B
Pharmaceuticals Growth	7136.10%	-38.95%	193.25%	-96.39%	398.02%
Total	9.53B	131.65M	215.66M	73.54M	2.04B
Total Growth	7136.10%	-38.95%	193.25%	-96.39%	398.02%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
South Korea	9.51B	501.08M	215.66M	39.32M	17.73M
South Korea Growth	1797.19%	132.35%	448.53%	121.75%	39.11%
China	20.09M	39.30M	-	34.23M	2.02B
China Growth	-48.87%	-	-	-98.30%	409.57%
Total	9.53B	540.38M	215.66M	73.54M	2.04B
Total Growth	1662.94%	150.57%	193.25%	-96.39%	398.02%

Source: S&P Global Market Intelligence.